BRIEF-Celgene International says European Commission approved Revlimid

* European Commission approved Revlimid for treatment of

adult patients with relapsed or refractory mantle cell lymphoma

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1...

Read more